Thermo Completes Sale of Cole-Parmer to GTCR
News Aug 20, 2014
The business, which was part of the Laboratory Products and Services Segment, had approximately $230 million in revenues for full year 2013.
Multidisciplinary Study Suggests New Strategy for Drug DiscoveryNews
A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.READ MORE